With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast, in anticipation of a potential ...

The science-services and instruments provider is expanding operations in the U.S. as companies rearrange manufacturing to avoid new global tariffs. The pharmaceutical industry has long been exempt ...

In recent days, Boston Scientific announced a forthcoming CFO change, a Cambridge biotech undertook a 1-for-20 reverse stock ...

Thermo Fisher kicked off 2025 with strong Q1 results, banking $10.36 billion in revenue and flexing its R&D muscles. CEO Marc ...

Xtrackers S&P 500 Swap UCITS ETF - 1C USD ACC 5% SPDR S&P 500 UCITS ETF - USD DIS 5% iShares Core S&P 500 UCITS ETF USD - DIS 5% ...